Frontier Wealth Management LLC Windtree Therapeutics Inc Transaction History

Frontier Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$1.66 - $2.27 $99,600 - $136,200	-60,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.68 - $2.79 $100,800 - $167,400	60,000 New	60,000 $137,000
Q1 2021 May 17, 2021	SELL	$2.14 - $6.18 $128,400 - $370,800	-60,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.3 - $9.96 $198,000 - $597,600	60,000 New	60,000 $420,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $113M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Wealth Management LLC with notifications on news.